Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Multipurpose Biosensors Rely on Luciferase to Light up Target Molecules

By LabMedica International staff writers
Posted on 05 Aug 2015
A team of Swiss molecular biologists developed a luminescent marker system that sends out a light signal after binding to a specific target molecule.

Investigators at Ecole Polytechnique Fédérale de Lausanne (Switzerland) attached a small chemical tag to the enzyme luciferase, which catalyzes the light produced by fireflies. More...
The tag molecule prevented luciferase from producing light, but when the tag detected its target protein, it released luciferase and attached to that protein instead. As a result, luciferase was free to emit a light, which was the signal that the target molecule had been found.

As proof-of-principle the investigators described in the July 22, 2015, online edition of the journal Nature Communications a luciferase controlled by human carbonic anhydrase whose activity could be controlled by proteins or small molecules in vitro and on living cells, and novel fluorescent and bioluminescent biosensors.

"You can think of the tagged luciferase as a cyborg molecule," said senior author Dr. Kai Johnsson, professor of chemistry at Ecole Polytechnique Fédérale de Lausanne. "Half bio, half synthetic. How could you make luciferase sensitive to the presence of another protein just through mutations? It is a lot of work. With this chemical trick, all we have to worry about is designing an appropriate tag that can recognize the target protein. This is a generalized design. It shows how you can exploit synthetic chemistry to create sophisticated biosensor proteins."

Related Links:
Ecole Polytechnique Fédérale de Lausanne



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.